Safety and Efficacy Study of DSC127 in Treating Subjects With Diabetic Ulcers
Status:
Completed
Trial end date:
2011-05-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to assess if the experimental drug, DSC127, is safe, how well it
can be tolerated, and how different doses effect the healing of the chronic foot ulcers in
diabetic subjects.
Phase:
Phase 2
Details
Lead Sponsor:
US Biotest, Inc.
Collaborators:
Derma Sciences, Inc. Integra LifeSciences Corporation National Institutes of Health (NIH)